Sponsor

University of Saskatchewan

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of Saskatchewan appears in 69 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials69
Recruiting shown9
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
N95 Masks for Lung Health While Golfing During Wildfire SeasonNCT07620691 · lead sponsor · 2026-05-26
RECRUITING
Pasteurized Donor Human Milk for HIV-Exposed Infants: A Pilot StudyNCT06955715 · lead sponsor · 2025-04-15
RECRUITING
Impact of Milk and Yogurt Supplementation on Bone Health, Body Composition, and Gut Microbiota in Canadian Young AdultsNCT06265246 · lead sponsor · 2024-09-01
RECRUITING
Canadian Bone Strength Development StudyNCT06287840 · lead sponsor · 2024-04-01
RECRUITING
Stretching vs Walking for Lowering Blood PressureNCT05252208 · lead sponsor · 2022-03-28
RECRUITING
Evaluation of IRDye800CW-nimotuzumab in Lung Cancer SurgeryNCT04459065 · lead sponsor · 2020-09-01
RECRUITING
Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)NCT04235114 · lead sponsor · 2020-02-01
RECRUITING
Intermittent Low Oxygen Breathing: A First Study Testing Different Disease Stages in People Living With MSNCT07631143 · lead sponsor · 2026-07-01
NOT_YET_RECRUITING
Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's DiseaseNCT07178678 · lead sponsor · 2025-11-01
NOT_YET_RECRUITING
Evaluating the Impact of Single Dose Tiotropium on Allergen-induced Early Asthmatic ResponseNCT06679465 · lead sponsor · 2025-01-01
NOT_YET_RECRUITING
Reversibility of Methacholine Induced BronchoconstrictionNCT05977699 · lead sponsor · 2024-01-12
COMPLETED
Examining Different Modes of Exercise for Acute Reduction in Blood PressureNCT06628635 · lead sponsor · 2024-01-04
COMPLETED
Examining the Effects of a Remote Pulmonary Rehabilitation Program in the Severe Asthma Population.NCT06150300 · lead sponsor · 2024-01-01
NOT_YET_RECRUITING
Wheeling to Healing: A Novel Method for Improving Healing of Diabetic Foot UlcerationNCT04257565 · lead sponsor · 2022-05-01
UNKNOWN
Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild AsthmaNCT05113615 · lead sponsor · 2021-12-13
COMPLETED
Neuromodulation in MS Using Translingual StimulationNCT05275049 · lead sponsor · 2021-07-05
UNKNOWN
68Ga-PSMA PET/CT in Prostate CancerNCT04684628 · lead sponsor · 2020-12-09
SUSPENDED
Tiotropium Efficacy Against Allergen Induced Early Asthmatic ResponsesNCT04648813 · lead sponsor · 2020-11-13
COMPLETED
Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled AsthmaNCT04167280 · lead sponsor · 2019-11-05
COMPLETED
Individualized Physiotherapy and Activity Coaching for Multiple SclerosisNCT04027114 · lead sponsor · 2019-07-12
COMPLETED
Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled TrialNCT03980990 · lead sponsor · 2019-06-17
UNKNOWN
Stretching Versus Walking From Reducing Blood PressureNCT03947996 · lead sponsor · 2019-05-15
COMPLETED
Ketamine Co-induction for Patients With Major Depressive DisorderNCT03666494 · lead sponsor · 2018-12-01
UNKNOWN
Inhaled Allergen Challenge Methodology: Assessment of a Vibrating Mesh Nebulizer for Allergen AdministrationNCT03491358 · lead sponsor · 2018-11-27
COMPLETED
Effect of Fluticasone Furoate on Methacholine ChallengeNCT03898466 · lead sponsor · 2018-10-30
COMPLETED
Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast CancerNCT03407768 · lead sponsor · 2018-07-01
COMPLETED
The Effect of Deep Inhalation on Mannitol ResponsivenessNCT03505489 · lead sponsor · 2018-06-01
COMPLETED
Effect of Vilanterol on Methacholine Challenge ResultsNCT03315000 · lead sponsor · 2017-10-13
COMPLETED
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in SaskatchewanNCT03075709 · lead sponsor · 2017-09-30
UNKNOWN
Physiotherapist-guided Home Exercise in Moderate to Severe MSNCT03039400 · lead sponsor · 2017-03-06
COMPLETED
Multiple Sclerosis and PilatesNCT03006900 · lead sponsor · 2016-12-01
COMPLETED
Investigation of Novel Procedure for Methacholine Challenge TestingNCT02965482 · lead sponsor · 2016-11-01
COMPLETED
Effect of a LAMA and a uLABA on the Methacholine Dose-response CurveNCT02953041 · lead sponsor · 2016-10-01
COMPLETED
Using [18F]FDOPA PET/CT to Monitor the Effectiveness of Fetal Dopaminergic Grafts in Parkinson Disease PatientsNCT02538315 · lead sponsor · 2016-10-01
TERMINATED
A Comparison of Three Nebulizers for Standard Clinical and Research Use in Methacholine Challenge TestingNCT02822859 · lead sponsor · 2016-06-01
COMPLETED
Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine ChallengeNCT02622243 · lead sponsor · 2015-11-01
COMPLETED
Flaxseed Lignan Supplementation in Elderly Participants With Stage I HypertensionNCT02391779 · lead sponsor · 2015-05-01
COMPLETED
Airway Response to Repeat Allergen Challenge and the Effect of Ibuprofen in Mild Atopic AsthmaNCT02327234 · lead sponsor · 2014-12-01
COMPLETED
Vascular Abnormalities in Idiopathic Parkinson's DiseaseNCT02045420 · lead sponsor · 2013-12-01
UNKNOWN
Viral Illness in Pediatric Critical Care: Incidence Timing & Severity of Associated Heart Dysfunction & Acute Kidney InjuryNCT01924663 · lead sponsor · 2013-09-01
COMPLETED
Does Ultrasound Guidance Improve Time to Perform a Spinal or Number of Attempts in Obese Patients?NCT01680913 · lead sponsor · 2013-01-01
COMPLETED
Prevention of Renal Complications of Diabetes With ThiamineNCT01725412 · lead sponsor · 2012-11-01
UNKNOWN
Change in Airway Responsiveness After Allergen ExposureNCT01699594 · lead sponsor · 2012-10-01
COMPLETED
Single Oral Dose of BeneFlax to Healthy Young and Older AdultsNCT01531569 · lead sponsor · 2011-12-01
COMPLETED
Mannitol (Aridol) and Methacholine (Provocholine) ResponsivenessNCT01642745 · lead sponsor · 2011-11-01
COMPLETED
Salbutamol Tolerance OnsetNCT01338311 · lead sponsor · 2011-03-01
COMPLETED
Effects of Caffeine on Methacholine Challenge and Exhaled Nitric Oxide Levels.NCT01057875 · lead sponsor · 2010-01-01
COMPLETED
Methacholine Challenge: Comparison of Doubling and Quadrupling Methacholine Dose Regimes Using the Tidal Volume MethodNCT00890539 · lead sponsor · 2009-02-01
COMPLETED
Sleep Disordered Breathing and Gestational HypertensionNCT00757718 · lead sponsor · 2008-12-01
COMPLETED
Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway HyperresponsivenessNCT00605410 · lead sponsor · 2008-01-01
COMPLETED
Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary DiseaseNCT00440245 · lead sponsor · 2007-02-01
COMPLETED
Airway Responses to Montelukast and Desloratadine.NCT00424580 · lead sponsor · 2007-01-01
COMPLETED
The Correlation Between Airway Inflammation and Loss of Deep Inhalation Bronchoprotection in AsthmaticsNCT00404677 · lead sponsor · 2006-06-01
COMPLETED
Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major DepressionNCT03207438 · lead sponsor · 2006-04-01
COMPLETED
Prevalence Study of Sleep Apnea in Women With PreeclampsiaNCT00259688 · lead sponsor · 2006-02-01
COMPLETED
Benefits of Exercise and Education for Individuals With Parkinson's Disease (BEEP)NCT00167453 · lead sponsor · 2005-09-01
COMPLETED
Helium-Hyperoxia and 6MWT Distance in COPDNCT00394225 · lead sponsor · 2005-07-01
COMPLETED
Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLCNCT00259675 · lead sponsor · 2004-05-01
COMPLETED
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)NCT05017311 · collaborator · 2023-01-20
RECRUITING
International Severe Asthma Registry: Canadian CohortNCT04045587 · collaborator · 2018-11-06
RECRUITING

Drugs studied in this sponsor's trials

22 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Saskatchewan as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo6
albuterol2
fluticasone furoate2
glycopyrronium2
mannitol2
brexpiprazole1
escitalopram1
fentanyl1
placebo RxCUI 8375 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 6 trials albuterol RxCUI 435 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials fluticasone furoate RxCUI 705022 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials glycopyrronium RxCUI 1546438 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials mannitol RxCUI 6628 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials brexpiprazole RxCUI 1658314 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial escitalopram RxCUI 321988 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial fentanyl RxCUI 4337 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial helium RxCUI 5140 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ibuprofen RxCUI 5640 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial indacaterol RxCUI 1114326 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ipratropium bromide RxCUI 203212 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ipratropium Metered Dose Inhaler RxCUI 746447 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ketamine hydrochloride RxCUI 203184 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial metformin RxCUI 6809 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial methacholine RxCUI 155080 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial methacholine chloride RxCUI 40165 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial oxygen RxCUI 7806 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial propofol RxCUI 8782 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial tezepelumab RxCUI 2587789 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial tiotropium RxCUI 69120 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial tiotropium bromide RxCUI 393575 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor58
collaborator11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.